FocusLeishmaniasis

Using Humans to Make a Human Leishmaniasis Vaccine

Science Translational Medicine  30 Apr 2014:
Vol. 6, Issue 234, pp. 234fs18
DOI: 10.1126/scitranslmed.3009118

You are currently viewing the abstract.

View Full Text

Log in


Abstract

The cellular immune response to peptide pools from conserved Leishmania antigens in leishmaniasis-immune individuals identified epitopes for a human DNA vaccine (Das et al., this issue).

View Full Text